SecProbe.io

Probe score transparency
Intelligence Terminal Search Topics Monthly Activity About

Probe Score Transparency

VERTEX PHARMACEUTICALS INC / MA (VRTX)
Score window: May. 30, 2025 to May. 29, 2026

Back View Correspondence
Probe Score
3.5 / 10
Letters
2
Latest Activity
May. 7, 2025
Version
v1

Score Breakdown

Letter Count
2.0
Sentiment / Tone
1.5
Keywords
0.0
Signals
0.0
Notable 8-K Modifier
0.0
Notable 8-K Count
0

Matched Signals

No stored keyword or signal matches were recorded for this score.

Filings In This Window

DateFormSentimentUrgencySummaryOpen
Apr. 14, 2026 UPLOAD Neutral/Informational Low The SEC has completed its review of Vertex Pharmaceuticals' Form 10-K for the fiscal year ended December 31, 2025. They remind the company and its management of their responsibili… Read Filing EDGAR
Apr. 1, 2026 CORRESP Neutral/Informational Low Vertex Pharmaceuticals has submitted a response to the SEC's comment letter regarding their Form 10-K for the fiscal year ended December 31, 2025. The SEC requested more detailed … Read Filing EDGAR
Mar. 18, 2026 UPLOAD Concern from SEC High The SEC has conducted a limited review of Vertex Pharmaceuticals' Form 10-K for the fiscal year ended December 31, 2025, focusing specifically on the financial statements and rela… Read Filing EDGAR

Notable 8-Ks In This Window

No notable 8-Ks were stored for this company in the score window.